ATAI Launches Subsidiary Focused On Active Ingredient In Hallucinogenic Brews

July 22, 2020 Articles 7:21 pm

Psychedelics and biotech company ATAI Life Sciences announced Wednesday the launch of Viridia Life Sciences.

This wholly-owned subsidiary will be dedicated to the study and production of the DMT molecule (N,N-Dimethyltryptamine).

JOIN THE ATAI #INSIGHTNETWORK

Receive the latest news on atai and innovations in the space.

Email
submit

JOIN THE ATAI #INSIGHTNETWORK

Sign up to receive the latest news on atai.